Showing Results : 1-1 of 1
Sort By :
  • Expert Review of Vaccines: 2023, vol: , issue:
  • 1)- Sophie Marbaix, Annick Mignon, Audrey Taelman, Ahuva Averin, Mark Atwood, Jeffrey Vietri. Cost-utility of 20-valent pneumococcal conjugate vaccine compared to no vaccination and recommended alternative vaccines among Belgian adults. Expert review of vaccines. 2023, 22 (1): 1008-1021
    Cited : 4
    Read More
  • 2)- Shiqi Zhou, Yuan Luo, Jonathan F Lovell. Vaccine approaches for antigen capture by liposomes. Expert review of vaccines. 2023, 22 (1): 1022-1040
    Cited : 8
    Read More
  • 3)- Timo Vesikari, Joanne M Langley, Vlad Popovic, Francisco Diaz-Mitoma. PreHevbrio: the first approved 3-antigen hepatitis B vaccine. Expert review of vaccines. 2023, 22 (1): 1041-1054
    Cited : 3
    Read More
  • 4)- Charlotte Sorieul, Marta Dolce, Maria Rosaria Romano, Jeroen Codée, Roberto Adamo. Glycoconjugate vaccines against antimicrobial resistant pathogens. Expert review of vaccines. 2023, 22 (1): 1055-1078
    Cited : 11
    Read More
  • 5)- Yingping Chen, Xinpei Zhang, Lihui Gong, Zhenzhen Liang, Xiaosong Hu, Bo Xing, Yuting Liao, Lingfeng Yuan, Gang Chen, Huakun Lv. Safety, immunogenicity and immune-persistence of heterologous prime-boost immunization with BBIBP-CorV and ZF2001 against SARS-CoV-2 in healthy adults aged 18 years or older. Expert review of vaccines. 2023, 22 (1): 1079-1090
    Cited : 0
    Read More
  • 6)- Maria L Avila Agüero, Jose Brea Del Castillo, Luiza Helena Falleiros-Arlant, Eitan Berezín, Jose Cassio de Moraes, Carlos Torres-Martínez, Eduardo L Lopez, María E Castillo, Almudena Laris-Gonzalez, Fortino Solorzano, Angela Gentile, Juan Pablo Torres Torretti, Eduardo López-Medina. Risks of low vaccination coverage and strategies to prevent the resurgence of vaccine-preventable diseases in infants in the COVID-19 pandemic scenario: recommendations for Latin America and the Caribbean by the group of experts on infant immunization for Latin America. Expert review of vaccines. 2023, 22 (1): 1091-1101
    Cited : 1
    Read More
  • 7)- Ruyun Gao, Cuiling Zheng, Mengwei Yang, Liyuan Dai, Chen Chen, Jiarui Yao, Zhishang Zhang, Le Tang, Yuankai Shi, Xiaohong Han. Immunogenicity assessment of elder hepatocellular carcinoma patients after inactivated whole-virion SARS-CoV-2 vaccination. Expert review of vaccines. 2023, 22 (1): 1102-1113
    Cited : 0
    Read More
  • 8)- Claire E Mellott, Rafal Jaworski, Justin Carrico, Sandra E Talbird, Iwona Dobrowolska, Dominik Golicki, Goran Bencina, Micah Clinkscales, Eugenia Karamousouli, Amanda L Eiden, Ugne Sabale. Public health impact and return on investment of the pediatric immunization program in Poland. Expert review of vaccines. 2023, 22 (1): 1114-1125
    Cited : 0
    Read More
  • 9)- María L Avila-Agüero, Sebastián Ospina-Henao, Cristina Mariño, Mirella Vázquez-Rivera, Juan Pablo Torres, Dora Estripeaut, Rolando Ulloa-Gutierrez, Angela Gentile. Vaccination against pertussis in Latin American preterm and low-birth weight infants: experts opinion position for a neglected childhood age group. Expert review of vaccines. 2023, 22 (1): 1126-1135
    Cited : 0
    Read More
  • 10)- Jéssica L Chechi, Felipe A C da Costa, Julia M Figueiredo, Cássia M de Souza, Alessandro F Valdez, Daniel Zamith-Miranda, Aline C Camara, Carlos P Taborda, Joshua D Nosanchuk. Vaccine development for pathogenic fungi: current status and future directions. Expert review of vaccines. 2023, 22 (1): 1136-1153
    Cited : 4
    Read More
  • 11)- Alberto Cagigi, Bruno Douradinha. Have mRNA vaccines sentenced DNA vaccines to death? Expert review of vaccines. 2023, 22 (1): 1154-1167
    Cited : 4
    Read More
  • 12)- Rui Lin, Hui Jin, Xin Fu. Comparative efficacy of human papillomavirus vaccines: systematic review and network meta-analysis. Expert review of vaccines. 2023, 22 (1): 1168-1178
    Cited : 5
    Read More
  • 13)- Marco Del Riccio, Sara Boccalini, Claudia Cosma, Gabriele Vaccaro, Benedetta Bonito, Beatrice Zanella, Cristina Salvati, Duccio Giorgetti, Lisa Rigon, Massimiliano Alberto Biamonte, Matteo Monami, Paolo Bonanni, Angela Bechini. Effectiveness of pneumococcal vaccination on hospitalization and death in the adult and older adult diabetic population: a systematic review. Expert review of vaccines. 2023, 22 (1): 1179-1184
    Cited : 3
    Read More
  • 14)- Hui Han, Dan Zhao, Xinru Fang, Wenming Yang, Mengli Wang, Qianzhuo Liu, Luyao Wang, Zhihui Ji, Juan Zhang, Zhifeng Hou, Lei Hua, Yu Wang, Limin Wu. A retrospective cohort study: vaccination status and safety analysis of SARS-CoV-2 vaccine in patients with Wilson's disease. Expert review of vaccines. 2023, 22 (1): 1185-1195
    Cited : 0
    Read More
  • 15)- Florence Boisnard, Christine Manson, Laurence Serradell, Denis Macina. DTaP-IPV-HB-Hib vaccine (Hexaxim): an update 10 years after first licensure. Expert review of vaccines. 2023, 22 (1): 1196-1213
    Cited : 0
    Read More
  • 16)- Giacomo Casabona, Olivia Berton, Tina Singh, Markus Knuf, Paolo Bonanni. Combined measles-mumps-rubella-varicella vaccine and febrile convulsions: the risk considered in the broad context. Expert review of vaccines. 2023, 22 (1): 764-776
    Cited : 4
    Read More
  • 17)- Angel Shabu, Prasad S Nishtala. Analysis of the adverse events following the mRNA-1273 COVID-19 vaccine. Expert review of vaccines. 2023, 22 (1): 801-812
    Cited : 2
    Read More
  • 18)- Kimberly M Thompson, Dominika A Kalkowska, Kamran Badizadegan. Oral polio vaccine stockpile modeling: insights from recent experience. Expert review of vaccines. 2023, 22 (1): 813-825
    Cited : 3
    Read More
  • 19)- Ahmed Tawfik, Takahisa Kawaguchi, Meiko Takahashi, Kazuya Setoh, Izumi Yamaguchi, Yasuharu Tabara, Kristel Van Steen, Anavaj Sakuntabhai, Fumihiko Matsuda. Trivalent inactivated influenza vaccine response and immunogenicity assessment after one week and three months in repeatedly vaccinated adults. Expert review of vaccines. 2023, 22 (1): 826-838
    Cited : 1
    Read More
  • 20)- Cynthia Burman, Jamie Findlow, Helen S Marshall, Marco A P Safadi. National and regional differences in meningococcal vaccine recommendations for individuals at an increased risk of meningococcal disease. Expert review of vaccines. 2023, 22 (1): 839-848
    Cited : 4
    Read More
  • 21)- Brigitte Cheuvart, Bart Spiessens, Roy van Heesbeen, Derchieh Hung, Coralie Andrade, Joanna Korejwo-Peyramond, Fernanda Tavares-Da-Silva. Harmonizing the collection of solicited adverse events in prophylactic vaccine clinical trials. Expert review of vaccines. 2023, 22 (1): 849-859
    Cited : 0
    Read More
  • 22)- Karan Thakkar, Julia Spinardi, Moe H Kyaw, Jingyan Yang, Carlos Fernando Mendoza, Egemen Ozbilgili, Josie Dodd, Ben Yarnoff, Suda Punrin. Modelling the potential public health impact of different vaccination strategies with an omicron-adapted bivalent vaccine in Thailand. Expert review of vaccines. 2023, 22 (1): 860-870
    Cited : 1
    Read More
  • 23)- Ralph A Tripp. Understanding immunity to influenza: implications for future vaccine development. Expert review of vaccines. 2023, 22 (1): 871-875
    Cited : 3
    Read More
  • 24)- Eleana Tsoumani, John A Carter, Stina Salomonsson, Jennifer M Stephens, Goran Bencina. Clinical, economic, and humanistic burden of community acquired pneumonia in Europe: a systematic literature review. Expert review of vaccines. 2023, 22 (1): 876-884
    Cited : 12
    Read More
  • 25)- Catherine J Y Tsai, Jacelyn M S Loh, Kohtaro Fujihashi, Hiroshi Kiyono. Mucosal vaccination: onward and upward. Expert review of vaccines. 2023, 22 (1): 885-899
    Cited : 11
    Read More
  • 26)- Ting Du, Qiuxia Qu, Yawen Zhang, Qin Huang. No observable influence of COVID-19 inactivated vaccines on pregnancy and birth outcomes in the first trimester of gestation. Expert review of vaccines. 2023, 22 (1): 900-905
    Cited : 1
    Read More
  • 27)- Shahrul Mt-Isa, Justin R Chumbley, Emma L Crawford, Natalie Banniettis, Ulrike K Buchwald, Jessica Weaver, Thomas Weiss. An indirect treatment comparison (ITC) and matching-adjusted indirect comparison (MAIC) between a 15-valent (V114) and a 20-valent (PCV20) pneumococcal conjugate vaccine among healthy infants. Expert review of vaccines. 2023, 22 (1): 906-917
    Cited : 1
    Read More
  • 28)- Peter D Skidmore, Rocio Canals, Maheshi N Ramasamy. The iNTS-GMMA vaccine: a promising step in non-typhoidal Salmonella vaccine development. Expert review of vaccines. 2023, 22 (1): 918-920
    Cited : 4
    Read More
  • 29)- Felicitas Kühne, Katharina Achtert, Franziska Püschner, Dominika Urbanski-Rini, Juliane Schiller, Ernestine Mahar, Josephine Friedrich, Mark Atwood, Ralf Sprenger, Jeffrey Vietri, Christof von Eiff, Christian Theilacker. Cost-effectiveness of use of 20-valent pneumococcal conjugate vaccine among adults in Germany. Expert review of vaccines. 2023, 22 (1): 921-932
    Cited : 6
    Read More
  • 30)- Irnela Bajrovic, Maria A Croyle. Challenges in vaccine transport: can we deliver without the cold chain? Expert review of vaccines. 2023, 22 (1): 933-936
    Cited : 0
    Read More
  • 31)- Jovin J Y Choo, Christopher L D McMillan, Paul R Young, David A Muller. Microarray patches: scratching the surface of vaccine delivery. Expert review of vaccines. 2023, 22 (1): 937-955
    Cited : 6
    Read More
  • 32)- Yajie Gong, Xi Zhang, Xue Han, Baolan Chen, Yingxia Xu, Jitian Huang, Wenhan Yang, Xi Fu, Qiancui Wang, Zhongjun Li, Chunfeng Wu, Tianran Shen, Yuting Fan, Yingshi Dai, Yaping Qiao, Gang Zeng, Jikai Zhang, Qingsong Chen. Immune response and safety of inactivated SARS-CoV-2 vaccines during pregnancy: a real-world observational study. Expert review of vaccines. 2023, 22 (1): 956-963
    Cited : 1
    Read More
  • 33)- Richard Thomson-Luque, Thomas C Stabler, Kristin Fürle, Joana C Silva, Claudia Daubenberger. merozoite surface protein 1 as asexual blood stage malaria vaccine candidate. Expert review of vaccines. 2023, :
    Cited : 1
    Read More
 
 


Journal List
Links
Content Links
About Us

0